chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I got vaccinated, vaccines are painful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.     Linked case(s) involving the same patient:  US2022AMR157095   Additional Information: GSK Receipt Date: 28-Oct-2022 Reporter's Comment: This case was reported by a patient via interactive digital media. The patient never suffered from shingles disease. The patient received the Shingles vaccine and stated although the vaccines were something painful. The patient thought it was better to get vaccinated than to have the disease, greetings and blessings.  Additional Supportive Information: The follow up would not possible as no contact details were available. This case had been linked with US2022AMR157095, reported by same reporter for same patient.; Sender's Comments:  US-GSK-US2022AMR157095:Same reporter
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (When I get up to walk, the pain gets to the back of my legs), NECK PAIN (Pain from the injection site up to the neck) and VACCINATION SITE PAIN (Pain from the injection site up to the neck) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 016M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PAIN IN EXTREMITY (When I get up to walk, the pain gets to the back of my legs), NECK PAIN (Pain from the injection site up to the neck) and VACCINATION SITE PAIN (Pain from the injection site up to the neck). At the time of the report, PAIN IN EXTREMITY (When I get up to walk, the pain gets to the back of my legs), NECK PAIN (Pain from the injection site up to the neck) and VACCINATION SITE PAIN (Pain from the injection site up to the neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
General Fatigue that lasted a few hours; This spontaneous case was reported by an other health care professional and describes the occurrence of FATIGUE (General Fatigue that lasted a few hours) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced FATIGUE (General Fatigue that lasted a few hours). In January 2021, FATIGUE (General Fatigue that lasted a few hours) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment medication was reported.  The adverse reactions are lasted for few hours.   This case was linked to MOD-2021-391815, MOD-2021-391816 (Patient Link).
Very achy for next 2 days; triggered what I believe could be a very bad sciatica situation; Both legs ache, sitting feels like cuts off circulation, standing hurts less but hurts. Leaning forward front of legs hurt, standing flat, back of legs hurt; Have not been able to sleep for last 3 days due to the pain; This is a spontaneous report from a contactable consumer who reported for himself, a 65-year-old male patient who received the first fose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration in the left arm, on 28Jan2021 at 15:30, at the age of 65 years, at a single dose for COVID-19 immunization. There were no medical history and no concomitant medications. The patient had no known allergies. Patient was very achy for next 2 days, that seems consistent with all he have read. Reaction to vaccine has transitioned to or triggered what he believe could be a very bad sciatica situation. Both legs ache, sitting feels like cuts off circulation, standing hurts less but hurts. Leaning forward front of legs hurt, standing flat, back of legs hurt. Have not been able to sleep for last 3 days due to the pain. Tried lying on back, side, with pillows under legs, on floor with legs up on a chair. Have never had sciatica issue before. Patient experienced all reported events on 28Jan2021 at 19:30. The patient asked what can be done to eliminate the pain. Patient had no COVID prior vaccination, and was not COVID tested post vaccination. No treatment was received for the events. The outcome of the events was not recovered.  Information on the batch/lot number has been requested.
chills, fever, very tired, slept most of Thursday away, headache, light headed and dizzy walking down or upstairs
Pounding headache about 10-11 hours after vaccine administration. Took 1000mg Tylenol Extra Strength which did not help.  Chills about 12-13 hours after vaccine administration, lasting several hours. High fever (102.8) about 17 hours after vaccine administration (took additional 1000mg Tylenol at 2am) and fever was gone by 8am. Muscle/shoulder extreme tightness on right side (same arm receiving vaccine). Dizzy & light-headed 24 hours after vaccine administration (almost passed out). Headache remains 12+ hours since it began despite the multiple doses of Tylenol described.
9/15 Fever and Flu-like symptoms , all worsening over night and into the next day Anosmia started on 9/16 and at that point called health care nurse to arrange employee health test. Could not get anyone by phone and visited employee clinic to get a PCR. Was tested positive for CoVid and isolated for 10 days. Was prescribed busimide and took that for a week. Started supplements of D3, N-Acetylcysteine, C, Quercetin, Zinc, Famotidine, L-Arginine, and started a 10,000 step per day routine to get Nitric Oxide levels up. After this I was recovered.
Pt recvd 1st dose of Hep B vax on 19FEB91; approx 2 1/2 hrs post vax devel chest "heaviness", dyspnea, malaise, tachycardia, nausea & h/a;
Super sore/pain in the pea sized lump under her left collarbone; A pea size lump under her clavicle; This is a spontaneous report from a contactable consumer. A 29-year-old female patient (Patient) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN6207), via an unspecified route of administration, administered in Arm Left on 19Mar2021 12:00 (at the age of 29-year-old) as dose 1, single for COVID-19 immunization. The patient medical history was reported as none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously took tetanus vaccine on Jul2020, over the summer and experienced nausea and headache. The patient taken unspecified medication for years. On 26Mar2021, the patient experienced a pea size lump under her clavicle and then on 28Mar2021, the patient had super sore/pain in the pea sized lump under her left collarbone. The patient asked about the Covid 19 vaccine, her first dose. She has questions regarding the vaccine and reactions. She had no initial reaction at all but about a week later to the day of her first Covid 19 vaccine she noticed a pea sized lump under her left collarbone in the same side she got the Covid 19 vaccine. The pain in the pea sized lump under her left collarbone came a couple days later on about Sunday, 28Mar2021. It's pretty painful to wear even a sports bra, use a seatbelt or anything like that. Some of her friends said it might be a lymph node and she wanted to report it and see if it's been reported before. She needs to decide if she should go see a doctor. The outcome of the event a pea size lump under her clavicle was unknown and for event super sore/pain in the pea sized lump under her left collarbone was not recovered.  Follow up attempts are completed. No further information is expected.
Patient stated to MD at ED that approximately 20 minutes after receiving Td in his PMD office on 05/04/05 he started feeling pain, numbness and weakness in left arm extending up to the left side of his face.  His symptoms persisted and two days later he returned to his PMD and was sent to the ED.  On exam he was found to have fever (102.1) and approximately 4 x 5 cm induration of left shoulder(ad reported in the MD's notes).  He was treated with Solumedrol and sent home on Motrin, Prednisone and Benadryl.  Patient was to return to the medical clinic in 2 days but did not keep the appointment.  Multiple attempts to contact patient have been unsuccessful.
UNSPECIFIED SIDE EFFECTS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, once a total administered on 23-MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced unspecified side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified side effects was not reported. This report was non-serious.
This case was reported by a healthcare professional and described the occurrence of injection site cellulitis in a 5-year-old male subject who was vaccinated with KINRIX (GlaxoSmithKline). Concurrent vaccination included MMRV (non-GSK, Merck) given on 3 June 2014. The subject had no allergy and no previous reaction to vaccination. On 3 June 2014 the subject received 5th dose of KINRIX (intramuscular, right thigh). On 4 June 2014, 24 hours after vaccination with KINRIX, the subject experienced injection site cellulitis. The healthcare professional considered the event was clinically significant (or requiring intervention). The subject was treated with Bactrim. On 12 June 2014, the event was resolved. This was one of 3 cases reported by the same reporter.
Severe headache, low grade fever, chills, and nausea lasting for 3 days.
Redness, tender for about a week , itchy all over body for about 2 weeks
mom called stated that pt had been ill since got shots 8SEP93; low grade fever, fretful, poor appetite, sleeplessness, restlessness, all over body pain, loose stool, nausea; 16SEP93 ear infect;
This spontaneous report as received from a dental hygienist, the patient's mother, refers to a male patient of unknown age. On 11-JUN-2012 the patient was vaccinated with the first dose of GARDASIL. The dose and route were not reported. No other co-suspects and no concomitant medications were reported. On 12-JUL-2012 the patient received a second dose of GARDASIL No adverse symptoms were reported. No treatment information was reported. No further information was provided. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old male patient received BNT162b2 (BNT162B2), on 04Oct2021 at 11:00 as dose 3 (booster), single (Lot number: FA2596), in left arm and on 31Mar2022 as dose 4 (booster), single (Lot number: FK9894) at the age of 80 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Post polio syndrome" (unspecified if ongoing); "Known allergies: Sulfer" (unspecified if ongoing), notes: Known allergies: Sulfer. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19. Vaccine received Yes, is there any other medication in 2weeks: No, Antiviral details provided as COVID 19 Treatment Brand is Pfizer, Treatment start date is 01Sep2022, Treatment stop date is 05Sep2022, Lot number is 1923792A, Indication for Treatment of COVID-19, Adverse event experienced Feeling rough with rebound on 07Sep2022. Headache, upset stomach, very tired.
DIZZINESS AND LOW BLOOD PRESSURE. PARAMEDIC WAS CALLED AND THEY CHECKED VITALS AND SHE FELT BETTER AND WALKED BY HERSELF TO CAR AND LEFT. FOLLOW UP WAS DONE WITH PATIENT BY PHARMACIST AND PATIENT CONFIRMED SHE WAS FEELING OK.
One day post vax, the pt developed vomiting and diarrhea lasting 24-36 hours that self resolved. The pt reportedly recovered from this experience
Pt was leaving vaccination area when she passed out. She described it like she was listening to music and woke up with her mom over top of her. Patient has a history of fainting when seing needle. Ate water and crackers; color improved - released with mom
This nurse gave patient an extra dose of the influenza vaccine this season. Patient received his first flu dose on 09/13/2022. Patient came in for a scheduled flu vaccine with sibling and this nurse pulled siblings chart up twice and unknowingly and gave patient another flu vaccine on 12/22/2022 when he did not need a booster.  This nurse informed MD in office and called father to inform him. Father appreciative of call and was going to monitor for side effects- none reported to our office. This nurse documented the second vaccine and event in patient's chart.
This spontaneous report as received from a registered nurse refers to a 21 year old patient of unknown gender. The patient's medical history and concurrent conditions were not provided. It was reported that the patient was vaccinated with the first dose of GARDASIL 'when they were 16 years old". The patient was in the office on 16-FEB-2014, attempting to received the 2nd dose of GARDASIL and "they were now 21 years old". Information regarding dose, route and lot number were not provided. No adverse effects were reported. Additional information is not expected.
Rash all over trunk. Red bumps that look like small insect bites and feel like sandpaper, progressively getting worse since day 2
On 12/17/2022 at about 8:30 PM, I came home from visiting a friend. I was really fatigued, so I went to bed early. I felt like I had the flu, and I wasn't really able to sleep. I had intense body aches. At about 11:00 PM that night, I wondered if I had COVID-19. I took a home antigen test and got a positive result. I called my PCP's number and left a message asking for a callback. On the morning of 12/18/2022, a NP from the clinic called me and prescribed me Paxlovid, which I began taking that day. When I had COVID-19, I felt like I had the flu and pneumonia at the same time. I had body aches, shortness of breath, extreme fatigue, loss of appetite, depression, possibly fever and chills. I may have had a headache, but I don't really remember. I consumed as much water as possible. I monitored myself with a pulse oximeter, and my blood oxygen levels were always within a safe range. I was sick for a long time. I didn't test negative until maybe 1/3/2023 or 1/4/2023. I resumed working to the extent I was able on 1/5/2023. I work from home, and I could barely work for a couple of hours at a time without needing to nap. On 1/21/2023, I wrote a note concerning my extreme tiredness; this is unusual for me, because I'm normally pretty energetic. I'm not entirely sure, but I think that some of the fatigue began to diminish early in February 2023. It was possibly in mid-February 2023 that I was able to work without needing to nap. At the time of this writing, I feel fine and like I am back at my pre-COVID-19 energy levels. My depression has also lifted, and I feel fine emotionally.
pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in the arm) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse effect.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in the arm). At the time of the report, PAIN IN EXTREMITY (pain in the arm) outcome was unknown. Not Provided
Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022; Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022; This spontaneous case was reported by an emergency medical technician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2022 at 1:09 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 06-Feb-2022 at 1:09 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24 Dec 2021 and administered on 06 Feb 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient ethnicity reported. Concomitant medication of the patient was not reported. Vaccine administration time was given as 06 Feb 2022 at 13.09.22. The patient received booster dose. Vaccine received past its 30 days expiry date.Vaccine went into 2 to 8 Celsius thaw state on or about 24 Dec 2021. This vaccine was administered up until its manufacturing expiry date of 04 Apr 2022. No treatment information was provided by the reporter.   This case was linked to MOD-2022-542869 (Patient Link).
Patient was hospitalized due to breakthrough infection. Patient received J&J vaccine on 04/07/2021. Patient was hospitalized from 01/03/2022 - 01/15/2022. Below is copied from discharge summary:  Hospital Course:   Patient is a 70 y/o F with Hx of Chronic HfpEF, CKD, IDDM2, leukemia, COPD, depression, recent covid 19, chronic hypoxic resp failure on home O2 2L, who presents via EMS due to SOB, found with increase lung opacities concerning for developing HAP, AMS and possibly UTI.    Acute encephalopathy: -Resolve -No distress noted, awake and oriented -Likely from COVID 19 -ABG wo increased CO2 -UA WNL -CT head, no acute changes -Continue OP follow up w PCP   Acute on chronic hypoxic respiratory failure 2/2 COVID 19/ On home O2: -Resolve -Non septic -Chest Xray showed worsening PNA -Completed decadron for 4 days -Resume statin -Suportive care   Possible HAP: -Better -Non septic -Procalcitonin 0.30 -CT chest reviewed -Completed abx tx   Complicated UTI / Hx of ESBL UTI and Pseudomonas UTI -UA with trace LE -Prior UC grew ESBL, E coli resistant to fluoroquinolonas and pansensitive Pseudomonas -Now UC 5,000 cfu -Completed abx tx   Normocytic anemia: -Stable -B12, folate WNL -Iron 19   FTT / Functional decline / Severe protein calorie malnutrition: -Alb 2.5 -Boost with meals -Dietitian consulted   Demand ischemia: -Trop 58, pending delta 0 -Non ischemic EKG   CKD: -Cr 1.1 -Monitor   HTN: -Stable -Resume home meds   Depression: -Resume SSRI   Hyperglycemia 2/2 uncontrolled IDDM2 with neuropathy: -Better -Resume insulin -SS and accuchecks -Resume gabapentin   COPD: -Stable -Resume home inhalers   CAD: -Resume asa and statin   Chronic HFPEF/AICD -Euvolemic   Leukemia: -s/p tx -F/U OPD with Heme/Onc     Patient is discharged in stable condition with stable vital signs. All questions rearding hospital course and plan of care after discharge have been answered to satisfaction. Prescriptions for medications needed to be taken after discharge have been given to patient. Patient has been instructed to follow up with PCP within the next 7 days after discharge. Patient verbalizes understanding all given instructions and has no further doubts regarding discharge.
Chills, fatigue, headache, feeling feveris, ill,and weak; injection site swelling, stiffness and pain.
Soreness (Left Arm) x 2 days Fatigue (Intermittently) / 7 days Fever (Intermittently) / 7 days Body Ache/ 3days Chills /24 hrs.
fever; chills; This case was reported by a nurse via call center representative and described the occurrence of fever in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a week after receiving Shingrix, the patient experienced fever and chills. On an unknown date, the outcome of the fever and chills were recovered/resolved.   It was unknown if the reporter considered the fever and chills to be related to Shingrix.  Additional details were provided as follows: The age at the vaccination was not applicable. Within 24 to 72 hours, after receiving Shingrix, multiple patients experienced fever and chills and resolved within 72 hours. The reporter did not consent to follow up. This was 1 of 4 linked cases reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020211992:same reporter US-GLAXOSMITHKLINE-US2020211991:same reporter US-GLAXOSMITHKLINE-US2020211989:same reporter
Fever 102.3ºF max, beginning 12hrs after receiving dose lasting for 24hrs Low grade fever for an additional 24hrs Body aches Severe full body aches for 24hrs (completely incapacitated, brought to tears anytime I had to move) Moderate full body aches from 24hrs after receiving dose to present (extremely uncomfortable, leaving work early today) Nausea/Vomiting Nausea beginning 12hrs after dose Vomiting beginning 24hrs after dose, lasting 12hrs Diarrhea Beginning 24hrs after dose, lasting 24hrs Headache Beginning 12hrs after dose  Fatigue Beginning 12hrs after dose  As of 2/15/21, mild fatigue and body aches remain
Patient was not able to walk, step on his foot (where the injection has been made) for 4 days. He is limping until now.  Other symptoms are fussiness, lost of appetite.